Dan Brennan
Stock Analyst at TD Cowen
(4.08)
# 397
Out of 4,762 analysts
104
Total ratings
48.81%
Success rate
12.38%
Average return
Main Sectors:
Stocks Rated by Dan Brennan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TEM Tempus AI | Reinstates: Buy | $74 | $45.51 | +62.60% | 2 | Feb 5, 2025 | |
| WGS GeneDx Holdings | Maintains: Buy | $75 → $118 | $92.10 | +28.12% | 3 | Jan 7, 2025 | |
| EXAS Exact Sciences | Maintains: Buy | $82 → $86 | $46.35 | +85.54% | 6 | Nov 26, 2024 | |
| NTRA Natera | Maintains: Buy | $155 → $175 | $144.50 | +21.11% | 4 | Nov 13, 2024 | |
| CRL Charles River Laboratories International | Maintains: Buy | $240 → $250 | $170.59 | +46.55% | 5 | Nov 7, 2024 | |
| BRKR Bruker | Maintains: Hold | $72 → $70 | $44.96 | +55.69% | 1 | Nov 6, 2024 | |
| ILMN Illumina | Maintains: Buy | $166 → $177 | $84.20 | +110.21% | 12 | Nov 5, 2024 | |
| RVTY Revvity | Maintains: Buy | $141 → $144 | $111.52 | +29.12% | 3 | Nov 5, 2024 | |
| WAT Waters | Maintains: Hold | $363 → $410 | $373.13 | +9.88% | 3 | Nov 4, 2024 | |
| DHR Danaher | Maintains: Buy | $310 → $315 | $204.96 | +53.69% | 5 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $153 → $160 | $119.85 | +33.50% | 12 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $41 → $42 | $43.09 | -2.53% | 1 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $8.5 → $11 | $2.61 | +321.46% | 3 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $30 | $10.41 | +188.18% | 1 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $31 | $15.79 | +96.33% | 3 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $648 → $658 | $512.65 | +28.35% | 12 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $51 | $42.59 | +19.75% | 2 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $2.8 | $0.78 | +258.51% | 1 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $20 | $10.23 | +95.50% | 6 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $57 → $32 | $10.85 | +194.93% | 4 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $545 → $546 | $316.50 | +72.51% | 4 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $7 | $1.51 | +363.58% | 1 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $13 → $15 | $1.28 | +1,071.88% | 1 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $207 → $232 | $183.39 | +26.51% | 6 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $770 → $880 | $1,216.02 | -27.63% | 3 | Oct 7, 2020 |
Tempus AI
Feb 5, 2025
Reinstates: Buy
Price Target: $74
Current: $45.51
Upside: +62.60%
GeneDx Holdings
Jan 7, 2025
Maintains: Buy
Price Target: $75 → $118
Current: $92.10
Upside: +28.12%
Exact Sciences
Nov 26, 2024
Maintains: Buy
Price Target: $82 → $86
Current: $46.35
Upside: +85.54%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $155 → $175
Current: $144.50
Upside: +21.11%
Charles River Laboratories International
Nov 7, 2024
Maintains: Buy
Price Target: $240 → $250
Current: $170.59
Upside: +46.55%
Bruker
Nov 6, 2024
Maintains: Hold
Price Target: $72 → $70
Current: $44.96
Upside: +55.69%
Illumina
Nov 5, 2024
Maintains: Buy
Price Target: $166 → $177
Current: $84.20
Upside: +110.21%
Revvity
Nov 5, 2024
Maintains: Buy
Price Target: $141 → $144
Current: $111.52
Upside: +29.12%
Waters
Nov 4, 2024
Maintains: Hold
Price Target: $363 → $410
Current: $373.13
Upside: +9.88%
Danaher
Oct 23, 2024
Maintains: Buy
Price Target: $310 → $315
Current: $204.96
Upside: +53.69%
Aug 22, 2024
Maintains: Buy
Price Target: $153 → $160
Current: $119.85
Upside: +33.50%
Aug 8, 2024
Maintains: Buy
Price Target: $41 → $42
Current: $43.09
Upside: -2.53%
Aug 8, 2024
Maintains: Neutral
Price Target: $8.5 → $11
Current: $2.61
Upside: +321.46%
Aug 7, 2024
Maintains: Hold
Price Target: $28 → $30
Current: $10.41
Upside: +188.18%
Jul 29, 2024
Maintains: Buy
Price Target: $28 → $31
Current: $15.79
Upside: +96.33%
Jul 25, 2024
Maintains: Buy
Price Target: $648 → $658
Current: $512.65
Upside: +28.35%
Jul 23, 2024
Maintains: Buy
Price Target: $48 → $51
Current: $42.59
Upside: +19.75%
May 13, 2024
Initiates: Buy
Price Target: $2.8
Current: $0.78
Upside: +258.51%
May 1, 2024
Maintains: Buy
Price Target: $21 → $20
Current: $10.23
Upside: +95.50%
May 1, 2024
Downgrades: Hold
Price Target: $57 → $32
Current: $10.85
Upside: +194.93%
Dec 8, 2023
Maintains: Outperform
Price Target: $545 → $546
Current: $316.50
Upside: +72.51%
May 31, 2023
Initiates: Outperform
Price Target: $7
Current: $1.51
Upside: +363.58%
Mar 31, 2023
Upgrades: Outperform
Price Target: $13 → $15
Current: $1.28
Upside: +1,071.88%
Mar 1, 2021
Upgrades: Buy
Price Target: $207 → $232
Current: $183.39
Upside: +26.51%
Oct 7, 2020
Downgrades: Sell
Price Target: $770 → $880
Current: $1,216.02
Upside: -27.63%